Internist-nephrologist
Prof.dr. J.I. (Joris) Rotmans, MD, PhD.
Area(s) of expertise:
Internal Medicine, Nephrology
Internal Medicine, Nephrology
Introduction
I am an internist-nephrologist and head of the subdepartment of Nephrology at LUMC.
After my PhD in Amsterdam, I started my training as internist which I interrupted for one year to work as postdoctoral researcher at the Australian Institute of Bioengineering and Nanotechnology in Brisbane, Australia. Since 2010, I combine clinical work as internist-nephrologist with vascular and renal research. I was member of the Dutch Guideline Committee on vascular access for hemodialysis (2020). Recently, I co-founded XS Innovations, a spin-off company of LUMC and TU Delft that aims to introduce vascular-access related innovations into clinical care. Furthermore, I am board member of NeoKidney, chairman of the thematic working group on vascular tissue engineering at TERMIS and president of the Vascular Access Society.
After my PhD in Amsterdam, I started my training as internist which I interrupted for one year to work as postdoctoral researcher at the Australian Institute of Bioengineering and Nanotechnology in Brisbane, Australia. Since 2010, I combine clinical work as internist-nephrologist with vascular and renal research. I was member of the Dutch Guideline Committee on vascular access for hemodialysis (2020). Recently, I co-founded XS Innovations, a spin-off company of LUMC and TU Delft that aims to introduce vascular-access related innovations into clinical care. Furthermore, I am board member of NeoKidney, chairman of the thematic working group on vascular tissue engineering at TERMIS and president of the Vascular Access Society.
Scientific research
My research relates to various aspects of chronic kidney disease and it linked to the LUMC themes Cardiovascular and Regenerative medicine of tissues and organs. A large proportion of his research focuses on vascular access for hemodialysis. In 2015, I received a VIDI grant from NOW for my research on vascular tissue engineering. Together with researchers from TU Delft, I’m currently working on a new concept for vascular access: the dynamic arteriovenous fistula (AVF). This is an AVF which is solely functional during hemodialysis, in order to avoid complications of the continuous high flow in AVFs. Our team has won the Venture Challenge in 2023 for this innovative approach. In addition, I’m thelocal-principle investigator of the TTV-Guide consortium, a Horizon 2020 program in which we aim to optimize immuunsuppression for patients after kidney transplantation. Furthermore, I’m working on novel methods for home monitoring of patienten with kidney disease.
